ArticleAAPS PharmSciTech2023
Exploring Sorafenib and Simvastatin Combination for Ferroptosis-Induced Cancer Treatment: Cytotoxicity Screening, In Vivo Efficacy, and Safety Assessment.
Kaushik Kuche et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it